StockWatch
·

Aelea Commodities Ltd Q2 FY27 Results

ACLDQ2 FY27 Results
Filing
MetricValue (₹ Cr)Q2 FY26
Revenue246.7442.1%
Total Income246.8242.0%
Expenditure234.2845.2%
PBT12.540.9%
Net Profit8.640.7%
OPM—
NPM3.50%1.51pp
EPS4.240.7%
View full financials
AELEA COMMODITIES · Q2 FY27 · THE VERDICT

42% Revenue Growth Derailed by Debt Burden and Margin Stagnation

Strong revenue growth masks flat profitability as debt burden and extended supply chains erode operational leverage. Management's value-chain integration strategy has inflated working capital without delivering promised margin relief.

09 Nov 2026 · 6 min read
Revenue

₹246.7 Cr

+42.1% YoY

Net Profit

₹8.6 Cr

−0.7% YoY (flat)

Debt

₹232 Cr

+109% YoY (doubled)

Finance Cost

₹8.39 Cr

(97% of PAT)

On the headline, Aelea Commodities delivered impressive revenue growth: ₹246.7 crore, up 42% year-on-year. But the profit line tells a different story. Net profit of ₹8.6 crore was essentially flat — down 0.7% — despite the revenue surge. Debt nearly doubled to ₹232 crore, and finance costs of ₹8.39 crore now consume 97% of the company's bottom line. The story of this quarter is not growth, but leverage: strong top-line momentum masked by structural headwinds that management's strategy has yet to solve.

Claims vs. What Holds Up

Management's on-call claims and their verdict against delivered results

Revenue ₹246 Cr, 42% YoY growth

Delivered ₹246.7 Cr, +42.1% YoY

Supported

PAT ₹863 lakhs, −0.7% YoY

Delivered ₹8.6 Cr (860 lakhs), −0.7% YoY

Supported (but masked by debt)

EBITDA margins improved vs last year

EBITDA ₹23 Cr on ₹246 Cr = 9.3%; per-kilo EBITDA ~₹7, price-linked not structural

Overstated

Finance cost not increased significantly

Debt doubled ₹111 → ₹232 Cr; cost rose ₹8.36 → ₹8.39 Cr; downplaying leverage scale

Contradicted

Deep value-chain integration will increase margin and reduce finance cost

WC extended 150–200 days, debt up ₹121 Cr, margin unchanged despite higher prices

Overstated

CNSL oil & solar completion mid/end December

Already 2–3 months delayed from Oct 31 target; timelines uncertain

Delayed

Where the Profit Comes From

EBITDA of ₹23 crore (9.3% margin) is being consumed by two forces. First, finance costs of ₹8.39 crore — driven by ₹232 crore in debt, itself inflated by an extended working capital cycle (now 150–200 days vs. the prior normal). Management frames this as temporary (commodity prices, Red Sea disruptions), but the reality is structural: direct African origin sourcing and deeper value-chain integration require longer transit (110–112 days) and higher inventory, locking in debt-service drag. Second, the per-kilo EBITDA of approximately ₹7 is held constant across a 150–200 rupee raw cashew price range — meaning margins compress as absolute prices rise (denominator effect) and expand only if raw cashew prices fall. There is no operational leverage, and there is no pricing power.

What Changed on This Call

Five structural shifts reshaping the risk profile
  • Borrowing structure: Debt ₹111 Cr (H2 FY26) → ₹232 Cr (H1 FY27). Management frames as working-capital-driven, but the scale (₹121 Cr increase, +109%) is material.

  • Supply chain extension: Sourcing shift to direct African import extended transit 35–45 days → 110–112 days. Increases inventory, working capital, and borrowing at scale.

  • Capex intensity: New ₹114 Cr capex approved; 30-month timeline (Nov 2026 → Sept 2029). Already 2–3 months behind on CNSL/solar; execution risk high.

  • Forward guidance transparency: Prior call: 'strong growth rates similar to FY26 into FY27.' This call: zero quantified FY27–28 revenue/PAT guidance.

  • Management tone: Analyst Aryan pressed hard on why deep value-chain integration has not improved margins; management deflected to price dynamics. Tone defensive, evasive.

The Market's View

The stock sits at ₹108.8 as of 6 November — down 68% from its all-time high of ₹344, oversold (RSI 26.8), and below all major moving averages (SMA20 ₹132.86, SMA50 ₹143.25, SMA200 ₹142.26). The 52-week range is ₹102.2–₹196; the stock trades near the midpoint but remains deeply underwater vs. its historical peak. Volume is trending up, suggesting some institutional interest despite weak price. Ownership is heavily promoter-concentrated (63.74%), with minimal FII exposure (0.07%) and zero DII interest. The market's skepticism is evident in the valuation: the 68% drawdown reflects not just this quarter's flat profit, but accumulated doubt about whether capex will convert debt into growth.

Risks, Ranked by Severity to a Holder

What should concern an investor most, and why

Debt-to-EBITDA ~10x; leverage erodes all upside

HIGH

Debt ₹232 Cr, EBITDA ₹23 Cr. Limited headroom if realization or EBITDA declines. Every ₹1 Cr loss in EBITDA costs ₹8.39 Cr in finance cost (unchanged), eroding PAT by ₹9.39 Cr (vs current ₹8.6 Cr).

Raw cashew commodity price linkage; no pricing power

HIGH

EBITDA per kilo ~₹7 across ₹150–200 raw cashew price range. 50% price swing = ±50% impact on PAT. Management explicit: margins hostage to commodity, not operational excellence.

Working capital cycle (150–200 days) + supply chain disruption

HIGH

Transit ₹110–112 days (vs 35–45 prior), inventory up, WC cycle extended. Requires ₹232 Cr in borrowing; further disruptions extend cycle further, raising finance costs.

Capex execution delays; 30-month timeline at risk

HIGH

CNSL/solar already 2–3 months behind. 60 MT expansion (140→200 MT) timeline is critical for organic growth post-FY28; slippage jeopardizes FY29 comps and compounds debt burden.

Margin dilution despite scale; no operational leverage

MEDIUM

42% revenue growth, −0.7% PAT growth. Deep value-chain promised margin expansion, delivered WC inflation. Risk: further scale without profitability growth erodes return on capital.

The Bull-Bear Ledger

  • BULL: 42% revenue growth is real, driven by volume + raw-material price inflation; capacity utilization 95–97% justifies expansion to 200 MT.

  • BULL: Direct African sourcing and FSSC 22,000 certification are strategic moats; long-term vision (1,000 MT by FY37) is credible.

  • BULL: Promoter-heavy ownership (63.74%) suggests insider confidence in the turnaround strategy.

  • BEAR: Profitability flat (−0.7% PAT) despite 42% revenue growth; zero operational leverage, execution risk on capex.

  • BEAR: Finance costs (₹8.39 Cr) consume 97% of PAT; leverage is the binding constraint, not operations.

  • BEAR: Management evasive on guidance and margin improvement; defensive on analyst scrutiny; capex timelines slipping.

  • BEAR: Margin improvement entirely commodity-price-dependent, not operational excellence; uncontrollable outcome.

The Debate

What to Watch Next

Four concrete signals that reset the debate
  • 1 · CNSL oil & solar commissioning (December 2026 target, already delayed)

    The first tangible test of whether capex unlocks new margin sources. Management has not quantified expected revenue or EBITDA from CNSL, only promised 'positive impact on H2.' Listen for: (a) actual commissioning date, (b) ramp-in timeline, (c) near-term margin contribution. If delayed further or unquantified, execution credibility collapses.

  • 2 · Raw cashew price direction in H2 FY27

    The margin recovery case hinges entirely on commodity deflation. If raw cashew prices stay at ₹200/kilo or rise further, PAT will compress or turn negative. Management explicit: −50% price move = ±50% PAT impact. Track global supply, India sourcing, and auction prices monthly.

  • 3 · Capex timeline adherence (30-month plan, already 2–3 months behind)

    The expansion from 140 MT → 200 MT is core to organic growth post-FY28. Further delays beyond the Nov 2026–Sept 2029 window signal execution risk and compound debt service burden. Expect management to provide monthly progress updates; slippage >3 months is a red flag.

  • 4 · Q3 FY27 PAT delivered — the post-CNSL read on leverage-adjusted growth

    If Q3 PAT shows organic growth (ex commodity inflation), the expansion thesis gains credibility. If Q3 PAT remains flat or negative, the debt burden is unsustainable and a capex write-down or equity raise becomes likely.

The Honest Close

Aelea Commodities delivered strong revenue growth this quarter, but the profit line reveals a company in structural transition — and not winning yet. Debt has doubled, working capital has ballooned, and finance costs now consume 97% of profit. The company is banking on capex (CNSL, solar, expansion) and commodity deflation to unlock margin recovery, but management has not quantified the path and is already slipping on timelines.

The market has priced this in: the stock is down 68% from its all-time high and deep in oversold territory. Promoter ownership is high, but institutional interest is minimal — a signal that even patient capital is unconvinced.

This is a hold, not a buy. Until CNSL/solar delivers on a quantified timeline and capex expansion converts to PAT growth (not just revenue), the stock remains leveraged to commodity prices and execution risk. The single number to track from here is Q3 FY27 PAT — if it remains flat or negative, the expansion thesis is in jeopardy.

Informational and educational content only. Not investment advice.